The Regents of the University of California, San Francisco (UCSF) has been awarded a $115,949 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The grant aims to delineate the spatial and temporal relationships between immune cells and fibroblasts in the visceral adipose tissue (VAT) of obese individuals. The research will leverage multimodal approaches including spatial sequencing, confocal microscopy, and flow cytometry to identify novel signaling pathways and cell populations that could serve as therapeutic targets for obesity-associated inflammation. The 2-year project, awarded on September 1, 2024, will be overseen by a team of expert mentors at UCSF and support the grantee's transition to becoming an independent physician-scientist focused on understanding and treating cardiovascular complications of obesity.
Generated 3/18/25, 2:02 AM